Alpha Tau Medical Ltd.
NASDAQ:DRTS
3.1 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.074 | 0.979 | 0.776 | 0.086 | 0 |
| Gross Profit
| -1.074 | -0.979 | -0.776 | -0.086 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 26.424 | 20.89 | 11.447 | 7.544 | 6.636 |
| General & Administrative Expenses
| 7.332 | 10.272 | 1.861 | 1.412 | 0.977 |
| Selling & Marketing Expenses
| 1.924 | 0.974 | 0.482 | 0.288 | 0.397 |
| SG&A
| 9.256 | 11.246 | 2.343 | 1.7 | 1.374 |
| Other Expenses
| -72.201 | 0 | 0 | 0 | 0 |
| Operating Expenses
| -35.68 | 32.136 | 13.79 | 9.244 | 8.01 |
| Operating Income
| 35.68 | -32.136 | -13.79 | -9.244 | -8.01 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -64.821 | -1.606 | -13.474 | 0.52 | -0.308 |
| Income Before Tax
| -29.141 | -33.742 | -27.264 | -8.724 | -8.318 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.016 | 0.02 | 0.007 | 0.158 | 0.146 |
| Net Income
| -29.157 | -33.762 | -27.271 | -8.882 | -8.464 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.42 | -0.53 | -0.67 | -0.22 | -0.13 |
| EPS Diluted
| -0.42 | -0.53 | -0.67 | -0.22 | -0.13 |
| EBITDA
| -28.028 | -32.742 | -13.215 | -9.158 | -7.944 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 |